A letter signed by the MS Society, MS Trust, Shift MS and leading neurologists calls on NICE, NHS England and drug manufacturer Roche to make ocrelizumab available for people with primary progressive MS.
Back in September, NICE announced that it would not be recommending ocrelizumab as an NHS treatment for early primary progressive MS. This decision was met with anger and dismay from people with MS and MS charities, and the MS Society started a petition, calling for urgent action.
Primary progressive MS (PPMS) can have a huge impact on the lives of people with the condition and their families. There are currently no approved treatments for PPMS and people with this form of MS experience disability significantly quicker than those with other forms. The lack of treatments that can modify their disease often forces them to rely on wheelchairs and mobility aids sooner, impacting on their independence. People do everything they can to minimise the impact PPMS has on their lives, but what they really want is access to treatment which will slow down the progression of their disease.
Clinical trials have shown that ocrelizumab can do this. It can slow the worsening of disability in early, active PPMS, allowing people to remain independent for longer and live as full a life as possible.
In October, NICE announced that it was pausing the publication of final guidance for ocrelizumab for PPMS, while further discussions took place between NICE, Roche and NHS England to try and reach a deal.
The MS Society has now delivered the petition, containing over 21,000 signatures, to these three bodies, calling on them to make ocrelizumab available on the NHS. This, in turn, would transform the lives of thousands of people with PPMS, and their families.
We stand with the MS Society on this issue. People with PPMS deserve better and it is critical that this decision is overturned as soon as possible. Along with the MS Society, Shift MS, and a number of leading neurologists, we have signed a letter, published in The Telegraph over the weekend, which sends a clear message to NICE. . . act now and ensure people living with PPMS can access the treatment they need and deserve.
Find out more
An MS Carers Week retrospective
9 Jun 2021 - 00:00
In this blog, Martin discusses the importance of raising awareness of caring and the contributions that carers make to the MS community.
Our approach to MS and caring
9 Jun 2021 - 00:00
Adam, who was diagnosed with MS eight years ago, and his wife, Sharon, share their MS caring journey as well as some tips for people in a similar position.
The challenges of choosing a DMD as a new mother
2 Jun 2021 - 00:00
Becoming a parent for the first time is often considered one of life’s biggest and most joyful moments. However, this time can also raise new challenges as discussed by Jenna who talks about her MS diagnosis, pregnancy and the challenge of choosing a new disease modifying drug after giving birth to her son.